Michael B. Polk's most recent trade in Colgate-Palmolive Co. was a trade of 2,884 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,884 | 2,884 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,220 | 25,803 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 5,703 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.65 per share. | 27 Feb 2023 | 5,703 | 29,142 (0%) | 0% | 71.7 | 408,620 | Common Stock |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Sale of securities on an exchange or to another person at price $ 73.48 per share. | 27 Feb 2023 | 5,559 | 23,583 (0%) | 0% | 73.5 | 408,494 | Common Stock |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,122 | 3,122 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 2,317 | 23,439 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 5,389 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.76 per share. | 02 Feb 2022 | 5,389 | 25,803 (0%) | 0% | 71.8 | 386,715 | Common Stock |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Sale of securities on an exchange or to another person at price $ 82.74 per share. | 02 Feb 2022 | 4,681 | 21,122 (0%) | 0% | 82.7 | 387,312 | Common Stock |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 3,611 | 3,611 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 2,159 | 20,414 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 5,583 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.83 per share. | 11 Feb 2021 | 5,583 | 23,090 (0%) | 0% | 67.8 | 378,695 | Common Stock |
| Colgate-Palmolive Co. | Michael B. Polk | Director | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 11 Feb 2021 | 4,835 | 18,255 (0%) | 0% | 79.3 | 383,174 | Common Stock |